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background:  Bleeding is the major concern for anticoagulation (OAC), especially in high bleeding risk patients. This multicenter study 
evaluated the safety and efficacy of OAC in AF patients with the history of ulcer.
Methods:  The study included 754 AF patients with healed ulcer at six tertiary hospitals. We compared composite end points including 
major adverse cardiac events (MACE) and major bleeding between patients with OAC (Group 1, n=327) and without (Group 2, n=427). 
MACE included stroke, myocardial infarction, pulmonary thromboembolism and other systemic embolism.
results:  CHADS2, CHA2DS2-VASc and HAS-BLED score were not different between the groups. During the follow up period of 3.3 ± 2.6 
years, 55 (17%) and 130 (30%) patients had MACE in group 1 and 2 (p=0.001). While 85 (26%) group 1 patients had major bleeding, 42 
(10%) group 2 patients had (p=0.001). Taken together, there was no significant difference in composite end points between group 1 and 2 
(37% vs. 40%, p=0.35). However, group 1 patients who achieved time in therapeutic range ≥ 60% in INR 2.0~3.0 showed better cumulative 
survival free from composite end points than group 2 (p=0.01).
Conclusion:  The OAC treatment in AF patients with healed ulcer decreased MACE and increased major bleeding simultaneously, making 
no difference in the composite end point. However, patients with OAC who were constantly maintained in optimal INR level showed better 
composite endpoint than those without OAC because of the dramatic reduction of MACE.
 
